PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8297414

Initial experience with single lead VDD system. Case study.

M Hassi·K Power·R Vlietstra
View original source ↗Export metadata ↓

Abstract

A single pass lead with dual chamber electrode system, designed for atrial and ventricular sensing and ventricular pacing (VDD), was implanted in a 63-year-old man with a history of syncope and second degree atrioventricular (AV) block. Intact VDD pacing function was confirmed at rest and during treadmill exercise. There were no postoperative complications. A single pass lead system that allows VDD mode pacing in patients with symptomatic AV block and competent sinus node function offers several advantages over traditional two lead dual chamber systems. These advantages include enhanced atrial sensing due to a differentially processed signal reliable for P wave detection and effective for rejection of far field ventricular signals, lowered cost and reduced implant time.

Explore related subjects

Cardiac Pacing, ArtificialElectrocardiographyEquipment DesignHeart BlockHumansMaleMiddle AgedPacemaker, ArtificialCase ReportsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Hassi, K Power, R Vlietstra. 1993. Initial experience with single lead VDD system. Case study.. https://pubmed.ncbi.nlm.nih.gov/8297414/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2001

Cardiac pacing. A review.

Pacing is a field of rapid clinical progress and technologic advances. Clinical progress in the 1990s included the refinement of indications for pacing as well as the use of pacemakers for new, nonbradycardiac indications, such as the treatment of cardiomyopathies and CHF and the prevention of atrial fibrillation. Important published data and studies in progress are shedding new light on issues of pacing mode selection, and they may influence future practice significantly. Important technologic advances include development of new rate-adaptive sensors and sensor combinations and the evolution of pacemakers into sophisticated diagnostic devices with the capability to store data and ECGs. Automatic algorithms monitor the patient for appropriate capture, sensing, battery status, and lead impedance, providing better patient safety and pacemaker longevity.

Cardiac Pacing, Artificial↗
PubMed2001

Electrical modulation of cardiac contractility: clinical aspects in congestive heart failure.

Heart failure is a highly prevalent disease in western society. Drug therapies aimed at increasing myocardial contractility have been associated with decreased survival. Several short and mid term clinical studies have suggested adjuvant or alternative therapies to congestive heart failure using modified pacing techniques that were aimed to increase contractility (e.g. Paired pacing) or restore synchrony of contraction (biventricular pacing). While delivery of paired pacing was abandoned during the early 70's, biventricular pacing has recently emerged as an adjuvant treatment to limited group of congestive heart failure patients with aberrant left ventricular conduction. In this brief review, we describe our initial safety and efficacy experience in patients with heart failure using a novel non-stimulatory electrical approach to the delivery of positive inotropic therapy to the failing myocardium. The study suggests that unlike modified pacing techniques, delivery of the signal to the left ventricle during the refractory period resulted in a rapid increase in myocardial contractility and improved hemodynamic performance. The near instantaneous contractility improvement achieved by this type of stimulus was shown to be safe and effective independently of the primary cause of heart failure or the function of the conduction system. Unlike pharmacologic treatments, which have a relatively constant effect, use of electrical stimuli may prove useful as a new therapeutic modality in the treatment of heart failure with which contractility can be improved when and as needed.

Cardiac Pacing, Artificial↗
PubMed2001

Pacemaker repetitive nonreentrant ventriculoatrial synchronous rhythm. A review.

Ventriculoatrial (VA) synchrony during dual chamber pacing can occur in any patient who has the ability to sustain repeated retrograde conduction. If the retrograde P wave is sensed, the result will be an endless loop tachycardia or repetitive reentrant VA synchrony. VA synchrony can also occur when a dual chamber pacemaker does not sense a retrograde P wave within the postventricular atrial refractory period. In this situation if the normally suprathreshold atrial stimulus at the end of the atrial escape interval is continually delivered when the atrial myocardium is physiologically refractory, the result will be a repetitive nonreentrant VA synchronous rhythm. Repetitive nonreentrant VA synchrony may produce unfavorable hemodynamic consequences and the pacemaker syndrome. It represents an example of functional atrial undersensing combined with functional loss of atrial capture. Management requires modification of the programmed settings of the pacemaker and utilization of certain algorithms designed for other functions but nevertheless effective in this situation.

Cardiac Pacing, Artificial↗